Variable | Mean ± SD Median (range) | p value | |
---|---|---|---|
NOM | OM | ||
Age < 55 years | 42.3% | 57.7% | n.s. |
Age > 55 years | 50.0% | 50.0% | |
Age (years) | 50.54 ± 18.17 | 49.87 ± 18.73 | n.s. |
49.35 (18.00–91.00) | 48.00 (17.00–85.60) | ||
No anticoagulant/antiplatelet drugs | 48.8% | 51.2% | n.s. |
Anticoagulant/antiplatelet drugs | 40.0% | 60.0% | |
HR (mean ± SD) | 85.95 ± 18.66 | 95.24 ± 21.07 | 0.009 |
Median (range) (bpm) | 80.00 (48.00–133.00) | 95.00 (55.00–145.00) | |
HR < 120 bpm | 58.7% | 41.3% | n.s. |
HR > 120 bpm | 46.8% | 53.2% | |
SBP(mmHg) | 120.40 ± 21.35 | 106.51 ± 26.92 | 0.002 |
120.00 (70.00–170.00) | 105.00 (53.00–167.00) | ||
SBP > 90 mmHg | 60.4% | 39.6% | 0.001 |
SBP < 90 mmHg | 21.7% | 78.3% | |
Shock index < 1 | 60.2% | 39.8% | 0.002 |
Shock index > 1 | 26.9% | 73.1% | |
AAST 1 | 100.0% | 0.0% | < 0.001 |
AAST 2 | 81.3% | 18.7% | |
AAST 3 | 44.1% | 55.9% | |
AAST 4 | 26.7% | 73.3% | |
AAST 5 | 0.0% | 100.0% | |
AAST ≤ 3 | 66.7% | 33.3% | < 0.001 |
AAST > 3 | 22.9% | 77.1% | |
WSES I | 86.4% | 13.6% | < 0.001 |
WSES II | 44.4% | 55.6% | |
WSES III | 44.4% | 55.6% | |
WSES IV | 20.0% | 80.0% | |
WSES I-II-III | 63.8% | 36.2% | < 0.001 |
WSES IV | 20.0% | 80.0% | |
ISS | 24.38 ± 12.68 | 32.05 ± 12.27 | < 0.001 |
22.00 (5.00–75.00) | 29.00 (9.00–66.00) | ||
ISS < 25 | 72.0% | 28.0% | 0.001 |
ISS > 25 | 40.9% | 59.1% | |
Lac | 3.01 ± 1.90 | 3.51 ± 1.85 | n.s. |
2.66 (0.80–9.24) | 3.08 (1.30–8.00) | ||
BE (mmol/L) | − 3.34 ± 3.82 | − 3.06 ± 2.88 | n.s. |
− 2.80 (− 14.50–2.10) | − 2.90 (− 9.50–1.80) | ||
pH | 7.32 ± 0.07 | 7.28 ± 0.16 | n.s. |
7.34 (7.13–7.43) | 7.29 (6.80–7.47) | ||
Hb (g/dL) | 13.31 ± 2.33 | 11.39 ± 2.63 | < 0.001 |
13.60 (5.60–16.80) | 11.70 (3.30–16.40) | ||
Hb > 12 g/dL | 66.7% | 33.3% | 0.001 |
Hb ≤ 12 g/dL | 37.9% | 62.1% | |
BE > − 5 mmol/L | 57.7% | 42.3% | n.s. |
BE < − 5 mmol/L | 66.7% | 33.3% | |
Brain injuries | 41.7% | 58.3% | n.s. |
No brain injuries | 56.0% | 44.0% | |
Associated abdominal lesions | 44.8% | 55.2% | n.s. |
No associated abdominal lesions | 60.6% | 39.4% | |
Trauma mechanism of injury | n.s. | ||
-Invested pedestrian | 72.7% | 27.3% | |
-Car | 44.7% | 55.3% | |
-Motorbike | 56.4% | 43.6% | |
-Bike | 60.0% | 40.0% | |
-Precipitation | 52.9% | 47.1% | |
-Others | 50.0% | 50.0% | |
Contrast blush | 42.4% | 57.6% | 0.010 |
No contrast blush | 68.9% | 31.1% | |
Pseudoaneurysm | 50.0% | 50.0% | n.s. |
No pseudoaneurysm | 61.4% | 38.6% | |
Hemoperitoneum at TC | 54.4% | 45.6% | n.s. |
Number of quadrants with hemoperitoneum | |||
- > 1 | 42.0% | 58.0% | < 0.001 |
- ≤ 1 | 69.4% | 30.6% | |
INR (s) | 1.12 ± 0.15 | 1.69 ± 1.11 | 0.001 |
1.15 (0.66–1.38) | 1.23 (1.04–5.05) | ||
INR > 1.5 s | 23.5% | 76.5% | 0.014 |
INR < 1.5 s | 55.7% | 44.3% | |
Fibrinogen (mg/dL) | 215.52 ± 53.98 | 168.23 ± 67.51 | 0.020 |
205.00 (156.0–491.00) | 173.00 (26.00–260.00) | ||
Fibrinogen ≤ 200 mg/dL | 38.1% | 61.9% | 0.031 |
Fibrinogen > 200 mg/dL | 60.4% | 39.6% | |
PLT/mm3 | 217.38 ± 49.76 | 198.29 ± 83.93 | n.s. |
220.00 (137.00–315.00) | 190.00 (156.00–401.00) | ||
Positive eco-fast | 33.9% | 66.1% | < 0.001 |
Negative eco-fast | 72.7% | 27.3% | |
RBC transfusion at the ED | 34.6% | 65.4% | 0.032 |
No RBC transfusion at the ED | 58.2% | 41.8% |